返回 Agenda
Session 2, Track A: Move from Reactive to Resilient - Canada’s Strategic Vision for Supply Chain Security and Global Harmonization
Session Chair(s)
Rebecca Humecky
Associate Director, Regulatory Affairs CMC, Cytokinetics Inc., United States
Oxana Iliach, PhD
Senior Director Regulatory Strategy, Certara, Canada
Session 2, Track A: Move from Reactive to Resilient - Canada’s Strategic Vision for Supply Chain Security and Global Harmonization
Learning Objective : 1. Explain how onshoring, complemented by near and friendshoring, strengthens Canada’s pharmaceutical supply chain resilience. 2. Analyze Health Canada regulatory and quality considerations influencing manufacturing relocation or expansion decisions. 3. Identify collaborative strategies that support reliable medicine supply while meeting Canadian regulatory expectations.
Speaker(s)
Chaitanya Koduri, DDS, MHS
Director, International Government and Regulatory Engagement, US Pharmacopeia, United States
Onshoring in the Americas: Health Canada Perspectives on Building Resilient Medicine Supply Chains
Maria Amaya, MS
Lead External Advocacy, North America , Genentech, A Member of the Roche Group, United States
From Reactive to Proactive: The Role of Canada in Harmonizing Global Shortage Prevention Requirements